General Announcement::Credit Rating by Fitch Ratings

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
12-Jul-2020 00:21:03
Status
New
Announcement Sub Title
Credit Rating by Fitch Ratings
Announcement Reference
SG200712OTHRUZ1X
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Glenmark would like to inform you that Fitch Ratings, as part of their annual review cycle, has reaffirmed the Company s credit rating at BB , outlook stable . This credit rating assigned to Glenmark is much higher than some of its global peers as mentioned in the enclosed report. The agency also affirmed the rating on Company s USD200 million 4.50% senior unsecured notes issued in 2016 at 'BB'.

Attachments

SGX_rating_2020.pdf
Total size =709K